Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 438

1.

Histamine H1 receptor on astrocytes and neurons controls distinct aspects of mouse behaviour.

Kárpáti A, Yoshikawa T, Naganuma F, Matsuzawa T, Kitano H, Yamada Y, Yokoyama M, Futatsugi A, Mikoshiba K, Yanai K.

Sci Rep. 2019 Nov 11;9(1):16451. doi: 10.1038/s41598-019-52623-6.

2.

Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease.

Hirai K, Minato S, Kaneko S, Yanai K, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Watano T, Fujino S, Ookawara S, Omoto K, Morishita Y.

Kidney Res Clin Pract. 2019 Sep 30;38(3):326-335. doi: 10.23876/j.krcp.19.027.

3.

Differences in cerebral and hepatic oxygenation in response to intradialytic blood transfusion in patients undergoing hemodialysis.

Minato S, Ookawara S, Ito K, Miyazawa H, Hayasaka H, Kofuji M, Uchida T, Morino J, Kaneko S, Yanai K, Mutsuyoshi Y, Matsuyama M, Ishii H, Shindo M, Kitano T, Aomatsu A, Ueda Y, Hirai K, Hoshino T, Morishita Y.

J Artif Organs. 2019 Dec;22(4):316-323. doi: 10.1007/s10047-019-01118-2. Epub 2019 Jul 24.

PMID:
31342286
4.

Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine.

Nakamura T, Hiraoka K, Harada R, Matsuzawa T, Ishikawa Y, Funaki Y, Yoshikawa T, Tashiro M, Yanai K, Okamura N.

Pharmacol Res Perspect. 2019 Jul 12;7(4):e00499. doi: 10.1002/prp2.499. eCollection 2019 Aug.

5.

Modeling evaporative emissions from parked gasoline cars based on vehicle carbon canister experiments.

Hata H, Yamada H, Yanai K, Kugata M, Noumura G, Tonokura K.

Sci Total Environ. 2019 Jul 20;675:679-685. doi: 10.1016/j.scitotenv.2019.04.112. Epub 2019 Apr 10.

PMID:
31039502
6.

Longitudinal changes in 18 F-THK5351 positron emission tomography in corticobasal syndrome.

Ezura M, Kikuchi A, Ishiki A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R, Yoshida S, Kobayashi J, Kobayashi M, Tano O, Nakashima I, Mugikura S, Iwata R, Taki Y, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M.

Eur J Neurol. 2019 Sep;26(9):1205-1211. doi: 10.1111/ene.13966. Epub 2019 May 11.

PMID:
30980575
7.

Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α.

Onishi H, Yamasaki A, Nakamura K, Ichimiya S, Yanai K, Umebayashi M, Nagai S, Morisaki T.

Anticancer Res. 2019 Mar;39(3):1179-1184. doi: 10.21873/anticanres.13227.

PMID:
30842147
8.

A case of posterior reversible encephalopathy syndrome in a patient undergoing automated peritoneal dialysis.

Kaneko S, Hirai K, Minato S, Yanai K, Mutsuyoshi Y, Ishii H, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Hoshino T, Ookawara S, Morishita Y.

CEN Case Rep. 2019 Aug;8(3):178-182. doi: 10.1007/s13730-019-00389-1. Epub 2019 Mar 4.

9.

Multiple Cerebral Hemorrhagic Lesions Depicted by Susceptibility-Weighted Imaging in a Patient with Down Syndrome: Case Report.

Yanai K, Ishida Y, Nishido H, Miyamoto S, Yamazaki K, Hoya K.

J Stroke Cerebrovasc Dis. 2019 May;28(5):e37-e38. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.024. Epub 2019 Feb 20.

PMID:
30797641
10.

Histamine N-Methyltransferase in the Brain.

Yoshikawa T, Nakamura T, Yanai K.

Int J Mol Sci. 2019 Feb 10;20(3). pii: E737. doi: 10.3390/ijms20030737. Review.

11.

MicroRNAs in peritoneal fibrosis: a systematic review.

Yanai K, Ishii H, Aomatsu A, Ishibashi K, Morishita Y.

Discov Med. 2018 Dec;26(145):271-280.

12.

Two cases of advanced stage rapidly progressive diabetic nephropathy effectively treated with combination therapy including RAS blocker, GLP-1 receptor agonist and SGLT-2 inhibitor.

Morino J, Hirai K, Kaneko S, Minato S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Hoshino T, Ookawara S, Hara K, Morishita Y.

CEN Case Rep. 2019 May;8(2):128-133. doi: 10.1007/s13730-019-00379-3. Epub 2019 Jan 20.

13.

Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.

Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E213. doi: 10.3390/ijms20010213. Review.

14.

Suppression of IFN-γ Production in Murine Splenocytes by Histamine Receptor Antagonists.

Kamei M, Otani Y, Hayashi H, Nakamura T, Yanai K, Furuta K, Tanaka S.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4083. doi: 10.3390/ijms19124083.

15.

A case of recurrent embolic stroke of undetermined source in a chronic kidney disease patient undergoing hemodialysis.

Shindo M, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Kitano T, Miyazawa H, Ito K, Ueda Y, Hirai K, Hoshino T, Ookawara S, Morishita Y.

Saudi J Kidney Dis Transpl. 2018 Sep-Oct;29(5):1245-1246. doi: 10.4103/1319-2442.243941. No abstract available.

16.

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.

Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K, Riku Y, Ishigaki S, Katsuno M, Miyao S, Kato K, Naganawa S, Harada R, Okamura N, Yanai K, Yoshida M, Sobue G.

Front Aging Neurosci. 2018 Oct 5;10:304. doi: 10.3389/fnagi.2018.00304. eCollection 2018.

17.

Corrigendum: Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Harada R, Okamura N, Furumoto S, Yanai K.

Front Neurosci. 2018 Sep 25;12:675. doi: 10.3389/fnins.2018.00675. eCollection 2018.

18.

Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Harada R, Okamura N, Furumoto S, Yanai K.

Front Neurosci. 2018 Aug 21;12:585. doi: 10.3389/fnins.2018.00585. eCollection 2018. Review. Erratum in: Front Neurosci. 2018 Sep 25;12:675.

19.

Targeting metals rescues the phenotype in an animal model of tauopathy.

Sedjahtera A, Gunawan L, Bray L, Hung LW, Parsons J, Okamura N, Villemagne VL, Yanai K, Liu XM, Chan J, Bush AI, Finkelstein DI, Barnham KJ, Cherny RA, Adlard PA.

Metallomics. 2018 Sep 19;10(9):1339-1347. doi: 10.1039/c8mt00153g.

PMID:
30168573
20.

Delayed peritoneal dialysis catheter-intestinal fistula.

Yanai K, Ueda Y, Minato S, Kaneko S, Mutsuyoshi Y, Ishii H, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Hirai K, Hoshino T, Ookawara S, Morishita Y.

Nephrology (Carlton). 2018 Sep;23(9):890-891. doi: 10.1111/nep.13204. No abstract available.

PMID:
30134506
21.

Site-Specific Labeling of F-18 Proteins Using a Supplemented Cell-Free Protein Synthesis System and O-2-[18F]Fluoroethyl-L-Tyrosine: [18F]FET-HER2 Affibody Molecule.

Yanai A, Harada R, Iwata R, Yoshikawa T, Ishikawa Y, Furumoto S, Ishida T, Yanai K.

Mol Imaging Biol. 2019 Jun;21(3):529-537. doi: 10.1007/s11307-018-1266-z.

PMID:
30112727
22.

A Case of Upper Ureter Rupture With Acute Kidney Injury.

Mutsuyoshi Y, Kaneko S, Minato S, Yanai K, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Hirai K, Hoshino T, Ookawara S, Morishita Y.

Clin Med Insights Case Rep. 2018 Jun 27;11:1179547618785134. doi: 10.1177/1179547618785134. eCollection 2018.

23.

Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.

Fujii T, Yanai K, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, Hirakata T, Shirabe K.

Anticancer Res. 2018 Aug;38(8):4927-4931. doi: 10.21873/anticanres.12809.

PMID:
30061271
24.

RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer.

Onishi H, Ichimiya S, Yanai K, Umebayashi M, Nakamura K, Yamasaki A, Imaizumi A, Nagai S, Murahashi M, Ogata H, Morisaki T.

Anticancer Res. 2018 Aug;38(8):4543-4547. doi: 10.21873/anticanres.12758.

PMID:
30061220
25.

Distinct Roles of Small GTPases Rac1 and Rac2 in Histamine H4 Receptor-Mediated Chemotaxis of Mast Cells.

Kuramasu A, Wakabayashi M, Inui M, Yanai K.

J Pharmacol Exp Ther. 2018 Oct;367(1):9-19. doi: 10.1124/jpet.118.249706. Epub 2018 Jul 18.

PMID:
30021868
26.

Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.

Hoshino T, Kaneko S, Minato S, Yanai K, Mutsuyoshi Y, Ishii H, Kitano T, Shindo M, Miyazawa H, Aomatsu A, Ito K, Ueda Y, Hirai K, Ookawara S, Morishita Y.

Ther Apher Dial. 2018 Dec;22(6):641-648. doi: 10.1111/1744-9987.12709. Epub 2018 Jul 16.

PMID:
30014626
27.

[Analysis of brain histamine clearance using genetically engineered mice].

Yoshikawa T, Nakamura T, Yanai K.

Nihon Yakurigaku Zasshi. 2018;152(1):16-20. doi: 10.1254/fpj.152.16. Japanese.

PMID:
29998947
28.

Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy.

Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Iwata R, Furumoto S, Tashiro M, Sasano H, Kitamoto T, Kudo Y, Yanai K, Furukawa K, Okamura N, Arai H.

Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.

29.

Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy.

Miyazawa H, Ookawara S, Ito K, Ueda Y, Yanai K, Ishii H, Mutsuyoshi Y, Kitano T, Shindo M, Aomatsu A, Hirai K, Hoshino T, Morishita Y.

PLoS One. 2018 Jun 25;13(6):e0199366. doi: 10.1371/journal.pone.0199366. eCollection 2018.

30.

First-Order Interacting Space Approach to Excited-State Molecular Interaction: Solvatochromic Shift of p-Coumaric Acid and Retinal Schiff Base.

Yanai K, Ishimura K, Nakayama A, Hasegawa JY.

J Chem Theory Comput. 2018 Jul 10;14(7):3643-3655. doi: 10.1021/acs.jctc.7b01089. Epub 2018 Jun 25.

PMID:
29889514
31.

Histamine elicits glutamate release from cultured astrocytes.

Kárpáti A, Yoshikawa T, Nakamura T, Iida T, Matsuzawa T, Kitano H, Harada R, Yanai K.

J Pharmacol Sci. 2018 Jun;137(2):122-128. doi: 10.1016/j.jphs.2018.05.002. Epub 2018 May 16.

32.

Whole-brain low-intensity pulsed ultrasound therapy markedly improves cognitive dysfunctions in mouse models of dementia - Crucial roles of endothelial nitric oxide synthase.

Eguchi K, Shindo T, Ito K, Ogata T, Kurosawa R, Kagaya Y, Monma Y, Ichijo S, Kasukabe S, Miyata S, Yoshikawa T, Yanai K, Taki H, Kanai H, Osumi N, Shimokawa H.

Brain Stimul. 2018 Sep - Oct;11(5):959-973. doi: 10.1016/j.brs.2018.05.012. Epub 2018 May 22.

33.

Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.

Yanai A, Itoh M, Hirakawa H, Yanai K, Tashiro M, Harada R, Yoshikawa A, Yamamoto S, Ohuchi N, Ishida T.

Tohoku J Exp Med. 2018 May;245(1):13-19. doi: 10.1620/tjem.245.13.

34.

Heparan sulfate in pancreatic β-cells contributes to normal glucose homeostasis by regulating insulin secretion.

Matsuzawa T, Yoshikawa T, Iida T, Kárpáti A, Kitano H, Harada R, Nakamura T, Sugawara A, Yamaguchi Y, Yanai K.

Biochem Biophys Res Commun. 2018 May 15;499(3):688-695. doi: 10.1016/j.bbrc.2018.03.213. Epub 2018 Apr 3.

PMID:
29605295
35.

Warfarin-related nephropathy with acute kidney injury in a patient with immunoglobulin A nephropathy.

Ishii H, Hirai K, Yanai K, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Mori H, Ookawara S, Ueda Y, Morishita Y.

CEN Case Rep. 2018 Nov;7(2):198-203. doi: 10.1007/s13730-018-0325-2. Epub 2018 Mar 24.

36.

Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks.

Kikuchi A, Nasir FBM, Inami A, Mohsen A, Watanuki S, Miyake M, Takeda K, Koike D, Ito T, Sasakawa J, Matsuda R, Hiraoka K, Maurer M, Yanai K, Watabe H, Tashiro M.

Hum Psychopharmacol. 2018 Mar;33(2):e2655. doi: 10.1002/hup.2655. Epub 2018 Mar 13.

37.

Practical microscale one-pot radiosynthesis of 18 F-labeled probes.

Iwata R, Pascali C, Terasaki K, Ishikawa Y, Furumoto S, Yanai K.

J Labelled Comp Radiopharm. 2018 Jun 15;61(7):540-549. doi: 10.1002/jlcr.3618. Epub 2018 Apr 17.

PMID:
29520821
38.

Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer.

Yamasaki A, Nakayama K, Imaizumi A, Kawamoto M, Fujimura A, Oyama Y, Nagai S, Yanai K, Onishi H.

Anticancer Res. 2017 Dec;37(12):6649-6654.

PMID:
29187440
39.

Histamine N-methyltransferase regulates aggression and the sleep-wake cycle.

Naganuma F, Nakamura T, Yoshikawa T, Iida T, Miura Y, Kárpáti A, Matsuzawa T, Yanai A, Mogi A, Mochizuki T, Okamura N, Yanai K.

Sci Rep. 2017 Nov 21;7(1):15899. doi: 10.1038/s41598-017-16019-8.

40.

Deterioration of Cerebral Oxygenation by Aortic Arch Calcification Progression in Patients Undergoing Hemodialysis: A Cross-Sectional Study.

Ito K, Ookawara S, Okochi T, Ueda Y, Kofuji M, Hayasaka H, Uchida T, Miyazawa H, Yanai K, Ishii H, Kitano T, Shindo M, Hirai K, Kaku Y, Hoshino T, Tanaka O, Tabei K, Morishita Y.

Biomed Res Int. 2017;2017:2852514. doi: 10.1155/2017/2852514. Epub 2017 Oct 3.

41.

[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia.

Lee H, Seo S, Lee SY, Jeong HJ, Woo SH, Lee KM, Lee YB, Park KH, Heo JH, Yoon CW, Kang JM, Cho J, Okamura N, Furumoto S, Yanai K, Na DL, Ido T, Villemagne VL, Noh Y.

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):62-69. doi: 10.1097/WAD.0000000000000216.

PMID:
29028649
42.

Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice.

Inoue SI, Takahara S, Yoshikawa T, Niihori T, Yanai K, Matsubara Y, Aoki Y.

Hum Mol Genet. 2017 Dec 1;26(23):4715-4727. doi: 10.1093/hmg/ddx354.

PMID:
28973166
43.

Development of molecular imaging probe targeted at Alzheimer's disease pathology.

Okamura N, Harada R, Furumoto S, Nakamura T, Yanai K, Kudo Y.

Nihon Yakurigaku Zasshi. 2017;150(4):172-176. doi: 10.1254/fpj.150.172. Japanese. No abstract available.

PMID:
28966214
44.

Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease.

Kang JM, Lee SY, Seo S, Jeong HJ, Woo SH, Lee H, Lee YB, Yeon BK, Shin DH, Park KH, Kang H, Okamura N, Furumoto S, Yanai K, Villemagne VL, Seong JK, Na DL, Ido T, Cho J, Lee KM, Noh Y.

Neurobiol Aging. 2017 Nov;59:210-219. doi: 10.1016/j.neurobiolaging.2017.08.008. Epub 2017 Aug 12.

PMID:
28890300
45.

Clinicopathological Features of Ductal Carcinoma In Situ from 18F-FDG-PET Findings.

Fujii T, Yanai K, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, Hirakata T, Kuwano H.

Anticancer Res. 2017 Sep;37(9):5053-5056.

PMID:
28870933
46.

Hedgehog Inhibition Upregulates TRK Expression to Antagonize Tumor Suppression in Small Cell Lung Cancer Cells.

Onishi H, Nakamura K, Nagai S, Yanai K, Yamasaki A, Kawamoto M, Imaizumi A, Morisaki T.

Anticancer Res. 2017 Sep;37(9):4987-4992.

PMID:
28870922
47.

Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease.

Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Nakamura T, Yoshikawa T, Iwata R, Tashiro M, Sasano H, Kitamoto T, Yanai K, Arai H, Kudo Y, Okamura N.

J Nucl Med. 2018 Apr;59(4):671-674. doi: 10.2967/jnumed.117.197426. Epub 2017 Sep 1.

48.

Array-Based Rational Design of Short Peptide Probe-Derived from an Anti-TNT Monoclonal Antibody.

Okochi M, Muto M, Yanai K, Tanaka M, Onodera T, Wang J, Ueda H, Toko K.

ACS Comb Sci. 2017 Oct 9;19(10):625-632. doi: 10.1021/acscombsci.7b00035. Epub 2017 Sep 8.

PMID:
28845964
49.

Organic Dye Adsorption by Amphiphilic Tris-Urea Supramolecular Hydrogel.

Takeshita J, Hasegawa Y, Yanai K, Yamamoto A, Ishii A, Hasegawa M, Yamanaka M.

Chem Asian J. 2017 Aug 17;12(16):2029-2032. doi: 10.1002/asia.201700708. Epub 2017 Jul 12.

PMID:
28699705
50.

A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.

Shidahara M, Thomas BA, Okamura N, Ibaraki M, Matsubara K, Oyama S, Ishikawa Y, Watanuki S, Iwata R, Furumoto S, Tashiro M, Yanai K, Gonda K, Watabe H.

Ann Nucl Med. 2017 Aug;31(7):563-569. doi: 10.1007/s12149-017-1185-0. Epub 2017 Jun 21.

PMID:
28639126

Supplemental Content

Support Center